http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009142827-A4

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fafbe17b6083714e0db15199d83b46f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e11d3368a25ac142fb5b97b39417874b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7bbbe2ceb7be0be49d61f3d083f2e3c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a933a0dd561e3e50b278738704d5c6e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_75eab90153f1d4664c103ca2116d3fa8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d43a40fde4067b3652d5a3eac40965a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_621349da96b1d0cce3e639716c28f8da
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65616
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6561
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-664
filingDate 2009-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f41151e0ba98623c5e24795953786c15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_335ff6963b0f0d339ce4bc968dbf13d6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64cbc3e4bced89b4a5db20a83eacf195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_517c23075bf51d23d24406e84ccd014a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6eece3ec1ddc1cca97800610bce28006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fab7058193ad6d0a6929cfebd0ac0990
publicationDate 2010-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2009142827-A4
titleOfInvention Compounds and methods for the treatment of viral infection
abstract The invention relates to compounds and methods for treating or preventing a viral infection, by administering a monophosphorylated prodrug of acyclovir or monophosphorylated derivative of an acyclovir prodrug to a subject suffering from or susceptible (to a viral infection, such as HlV infection.
priorityDate 2008-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398513
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393713
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393705
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397646
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393726
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394834
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395421
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555458
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394869
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457444288
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393661
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974

Total number of triples: 42.